NF1 microdeletion patients also have an increased risk ofmalignant peripheral nerve sheath tumours (MPNSTs); their lifetime MPNST risk is16–26%, rather higher than that of NF1 patients with intragenic NF1 mutations (8–13%). Here, NF1 is linked to malignant peripheral nerve sheath tumor.